高级搜索
吉非替尼对肺癌细胞株A549和H1975放射敏感度的影响及其机制[J]. 肿瘤防治研究, 2014, 41(04): 324-330. DOI: 10.3971/j.issn.1000-8578.2014.04.009
引用本文: 吉非替尼对肺癌细胞株A549和H1975放射敏感度的影响及其机制[J]. 肿瘤防治研究, 2014, 41(04): 324-330. DOI: 10.3971/j.issn.1000-8578.2014.04.009
Effects and Mechanism of Gefitinib on Radiosensitivity of Non-small Cell Lung Cancer Cell Lines A549 and H1975[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 324-330. DOI: 10.3971/j.issn.1000-8578.2014.04.009
Citation: Effects and Mechanism of Gefitinib on Radiosensitivity of Non-small Cell Lung Cancer Cell Lines A549 and H1975[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 324-330. DOI: 10.3971/j.issn.1000-8578.2014.04.009

吉非替尼对肺癌细胞株A549和H1975放射敏感度的影响及其机制

Effects and Mechanism of Gefitinib on Radiosensitivity of Non-small Cell Lung Cancer Cell Lines A549 and H1975

  • 摘要: 目的 本研究旨在探讨小分子表皮生长因子受体(epidermal growth factor receptor, EGFR)酪氨酸激酶抑制剂吉非替尼是否能增加肺癌细胞株A549和H1975的放疗敏感度及其机制。方法 选取两种非小细胞肺癌细胞株A549和H1975,分为单纯X线组和X线+吉非替尼组。单纯X线组采用单纯X 线照射,X线+吉非替尼组经10 μmol/L吉非替尼作用24 h后行X线照射。两株细胞不同分组细胞,采用克隆形成实验检测放射敏感度,免疫荧光激光共聚焦显微镜观察X线照射后不同时间点细胞核中磷酸化H2AX(γ-H2AX)亮点在细胞中的定位情况,Western blot法检测放疗后胞质胞核蛋白中EGFR的表达。结果 克隆形成实验中,A549 细胞X线+吉非替尼组在各放疗剂量点的SF2值(0.3475)低于单纯X线组(0.4833);H1975细胞X线+吉非替尼组与单纯X线组在各放疗剂量点的SF2值分别为0.3094和0.3207,无明显差异。免疫荧光结果显示,照射4 Gy 后各时间点X线+吉非替尼组A549细胞核中γ-H2AX亮点相比单纯X线多;单纯X线组和X线+吉非替尼组H1975细胞γ-H2AX亮点在各时间点无明显差异;Western blot结果显示,A549细胞经4 Gy照射后EGFR有入核现象,而预先经吉非替尼处理再接受4Gy照射,EGFR蛋白绝大部分位于细胞质内;H1975细胞,单纯X线组和X线+吉非替尼组EGFR蛋白均在细胞质中表达,胞核中几乎没有,且两组无明显差异。结论 吉非替尼能增加肺癌细胞株A549的放射敏感度,可能与阻止放疗后EGFR入核进行双链断裂(double strand break, DSB)修复有关;对H1975细胞无影响,与其放疗后EGFR 不入核相关。

     

    Abstract: Objective In this study, we specifi cally investigated the effect and the mechanism of gefi tinib, the tyrosine kinase inhibitor of epidermal growth factor receptor (EGFR), on radiosensitizing the nonsmall cell lung cancer (NSCLC) A549 and H1975 cell lines. Methods Two cell lines of NSCLC A549 and H1975 were divided into two groups, the X ray and X-ray plus gefi tinib groups. The former was irradiated with X rays only, and the latter was treated with 10μmol/L gefitinib for 24 h before irradiation under the same conditions. The cells were tested by cloning formation assay to identify the radiosensitivity of both groups. Immunostaining for confocal microscopy was used to observe the localization of nuclear γ-H2AX foci at different time points after irradiation. Nuclear EGFR expression was detected by Western blot after radiotherapy. Results The cloning formation assay revealed that the surviving fraction at 2 Gy (SF2) of the gefi tinib-interfering group (0.3475) was lower than that of the X ray group (0.4833) in A549 cells. There was no signifi cant difference between the SF2 values of the two respective groups in H1975 cells (0.3094 vs 0.3207). The confocal microscopy results found that the average number of γ-H2AX foci in the X ray plus gefi tinib group was more than that in the X ray group on every time point after 4 Gy irradiation in A549 cells. But there was no remarkable difference of the average number of γ-H2AX foci in H1975 cells between the two groups. Based on Western blot analyses, EFGR protein of A549 cells translocated into the nuclear in the X ray group after 4 Gy irradiation, but most of those located in cytoplasm in the X ray plus gefi tinib group. However, EGFR protein expressed in the nuclear of H1975 cells, seldom in the nucleus, for both treatment groups. Conclusion Gefi tinib enhances the radiosensitivity of A549 cells, which may be attributed to the suppression of EGFR transport into the nucleus to recover the double strand break(DSB). However, gefi tinib does not affect H1975 cells, related to EGFR remains in the cytoplasm after irradiation.

     

/

返回文章
返回